Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing and commercializing treatments for central nervous system (CNS) disorders. Its portfolio includes products for ADHD, Parkinson's disease, epilepsy, migraine, and dystonia. The company leverages proprietary technologies and strategic licensing to create innovative, patient-friendly medications, focusing on improving efficacy, safety, and adherence. It markets primarily in the U.S. through direct sales and partnerships.
This description was generated via AI from an annual report. Updated about 1 year ago.